TW200502398A - Use of peptidylarginine deiminase type IV - Google Patents
Use of peptidylarginine deiminase type IVInfo
- Publication number
- TW200502398A TW200502398A TW093101528A TW93101528A TW200502398A TW 200502398 A TW200502398 A TW 200502398A TW 093101528 A TW093101528 A TW 093101528A TW 93101528 A TW93101528 A TW 93101528A TW 200502398 A TW200502398 A TW 200502398A
- Authority
- TW
- Taiwan
- Prior art keywords
- rheumatoid arthritis
- peptidylarginine deiminase
- type
- gene
- effects
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/03—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amidines (3.5.3)
- C12Y305/03015—Protein-arginine deiminase (3.5.3.15)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
This invention relates to a method for evaluating the effects of a medicine for rheumatoid arthritis therapy, by using peptidylarginine deiminase type IV, and to a method for predicting the risk of incidence of a rheumatoid arthritis. In other words, this invention provids a method for evaluating the effects of a test substance as a medicine for rheumatoid arthritis therapy, which is using peptidylarginine deiminase gene type IV or its ortholog, or the inhibition effects against the protein encoded by the said gene as a marker. In addition, this invention provids a method for predicting the risk of incidence of a rheumatoid arthritis in a subject, which is based on the expression level of a mutant protein of peptidylarginine deiminase type IV having amino acids sequence of SEQ ID NO:21 or the gene(SEQ ID NO:20) in a specimen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003012774 | 2003-01-21 | ||
JP2003012738 | 2003-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200502398A true TW200502398A (en) | 2005-01-16 |
Family
ID=32775167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093101528A TW200502398A (en) | 2003-01-21 | 2004-01-20 | Use of peptidylarginine deiminase type IV |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP4503531B2 (en) |
TW (1) | TW200502398A (en) |
WO (1) | WO2004065633A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008029619A1 (en) * | 2006-09-07 | 2008-03-13 | Daiichi Sankyo Company, Limited | Ena antisense oligonucleotide having sequence-specific action |
JP5252339B2 (en) * | 2007-12-25 | 2013-07-31 | 地方独立行政法人東京都健康長寿医療センター | Method for measuring PAD4 and anti-PAD4 antibody and method for detecting rheumatoid arthritis |
WO2010115745A2 (en) * | 2009-03-30 | 2010-10-14 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis |
-
2004
- 2004-01-20 WO PCT/JP2004/000430 patent/WO2004065633A1/en active Application Filing
- 2004-01-20 TW TW093101528A patent/TW200502398A/en unknown
- 2004-01-20 JP JP2005508091A patent/JP4503531B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP4503531B2 (en) | 2010-07-14 |
JPWO2004065633A1 (en) | 2006-05-18 |
WO2004065633A1 (en) | 2004-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200745556A (en) | Biomarkers for liver fibrotic injury | |
DK1548032T3 (en) | KDR peptides and vaccines containing them | |
EP1696027A4 (en) | Hla-dr-binding antigen peptide derived from wt1 | |
NZ599590A (en) | Factor involved in latent infection with herpesvirus, and use thereof | |
Reynolds | Control of peptidoglycan synthesis in vancomycin-resistant enterococci: D, D-peptidases and D, D-carboxypeptidases | |
EP1005539A4 (en) | IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS | |
TW200502398A (en) | Use of peptidylarginine deiminase type IV | |
HUP0300155A2 (en) | Nitrilase from phodococcus rhodochrous ncimb 11216 | |
MXPA02009791A (en) | THE HIGH BONE MASS GENE OF 11q13.3. | |
WO2004055165A3 (en) | Glutathione-s-transferase test for susceptibility to parkinson's | |
Arrigoni et al. | Calcium-dependent regulation of genes for plant nodulation in Rhizobium leguminosarum detected by iTRAQ quantitative proteomic analysis | |
ATE373717T1 (en) | PDE8A AND ITS USE | |
WO2004070012A3 (en) | Cell-killing molecules and methods of use thereof | |
WO2007001943A3 (en) | Prefoldin 4 in the treatment and diagnosis of cancer | |
DE602006004966D1 (en) | INTRINSIC FACTOR FROM THE PIG | |
WO1999062315A3 (en) | Method for altering the activity of proteins of the pka signaling pathway | |
CA2367468A1 (en) | Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis | |
Sajdok et al. | A new method of age estimation based on the changes in human non-collagenous proteins from dentin | |
EP1580265A4 (en) | Nucleic acids isolated from neuroblastoma at stage 4s | |
ATE387460T1 (en) | METHOD AND KIT FOR ASSESSING THE OUTBREAK OF RHEUMATOID ARTHRITIS | |
HUP0203080A2 (en) | Prv-1 gene and use thereof | |
EP0856582A3 (en) | Inhibitor protein of transcription factors and its DNA | |
Ishida et al. | Development of a novel peptide inhibitor of subtilisin BPN′ | |
BR9914090A (en) | nucleic acids encoding a gamma subunit of the g protein involved in sensory transduction | |
WO2002086067A3 (en) | Mycobacterial sulfation pathway proteins and methods of use thereof |